BR9812922A - Isoquinolinas como inibidores de uroquinase - Google Patents

Isoquinolinas como inibidores de uroquinase

Info

Publication number
BR9812922A
BR9812922A BR9812922-8A BR9812922A BR9812922A BR 9812922 A BR9812922 A BR 9812922A BR 9812922 A BR9812922 A BR 9812922A BR 9812922 A BR9812922 A BR 9812922A
Authority
BR
Brazil
Prior art keywords
isoquinolines
urokinase inhibitors
urokinase
inhibitors
isoquinolins
Prior art date
Application number
BR9812922-8A
Other languages
English (en)
Inventor
Christopher Gordon Barber
Roger Peter Dickinson
Paul Vincent Fish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BR9812922A publication Critical patent/BR9812922A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Abstract

Patente de Invenção: <B>"ISOQUINOLINAS COMO INIBIDORES DE UROQUINASE"<D>. Compostos de fórmula (I): e os seus sais farmaceuticamente aceitáveis, em que um de R^ 1^ e R^ 2^ é H e o outro é N=C(NH~ 2~)~ 2~ ou NHC(=NH)NH~ 2~, e os outros substituintes são aqui definidos, são inibidores da uroquinase (uPA).
BR9812922-8A 1997-10-16 1998-10-05 Isoquinolinas como inibidores de uroquinase BR9812922A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721964.6A GB9721964D0 (en) 1997-10-16 1997-10-16 Isoquinolines
PCT/EP1998/006353 WO1999020608A1 (en) 1997-10-16 1998-10-05 Isoquinolines as urokinase inhibitors

Publications (1)

Publication Number Publication Date
BR9812922A true BR9812922A (pt) 2000-08-08

Family

ID=10820680

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812922-8A BR9812922A (pt) 1997-10-16 1998-10-05 Isoquinolinas como inibidores de uroquinase

Country Status (41)

Country Link
US (1) US6248738B1 (pt)
EP (1) EP1023268B1 (pt)
JP (1) JP3600794B2 (pt)
KR (1) KR20010031163A (pt)
CN (1) CN1275979A (pt)
AP (1) AP959A (pt)
AR (1) AR015964A1 (pt)
AT (1) ATE240943T1 (pt)
AU (1) AU727315B2 (pt)
BG (1) BG104328A (pt)
BR (1) BR9812922A (pt)
CA (1) CA2306782C (pt)
CO (1) CO4990959A1 (pt)
DE (1) DE69814894T2 (pt)
DK (1) DK1023268T3 (pt)
DZ (1) DZ2624A1 (pt)
EA (1) EA002632B1 (pt)
ES (1) ES2197514T3 (pt)
GB (1) GB9721964D0 (pt)
GT (1) GT199800159A (pt)
HN (1) HN1998000158A (pt)
HR (1) HRP20000217A2 (pt)
HU (1) HUP0004491A3 (pt)
ID (1) ID23913A (pt)
IL (1) IL135122A0 (pt)
IS (1) IS5412A (pt)
MA (1) MA26552A1 (pt)
NO (1) NO20001924L (pt)
NZ (1) NZ503390A (pt)
OA (1) OA11348A (pt)
PA (1) PA8461601A1 (pt)
PE (1) PE121299A1 (pt)
PL (1) PL340035A1 (pt)
PT (1) PT1023268E (pt)
SK (1) SK4872000A3 (pt)
TN (1) TNSN98185A1 (pt)
TR (1) TR200001010T2 (pt)
UY (2) UY25211A1 (pt)
WO (1) WO1999020608A1 (pt)
YU (1) YU21100A (pt)
ZA (1) ZA989412B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000005214A2 (en) * 1998-07-24 2000-02-03 Pfizer Inc. Isoquinolines as urokinase inhibitors
DE19940389A1 (de) 1999-08-25 2001-03-01 Wilex Biotechnology Gmbh Selektive Inhibitoren des Urokinase-Plasminogen Aktivators
ES2172376B1 (es) * 2000-01-28 2003-11-16 Servier Lab Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE10013715A1 (de) * 2000-03-20 2001-09-27 Wilex Biotechnology Gmbh Hochselektive Inhibitoren des Urokinase-Plasminogenaktivators
GB0026490D0 (en) * 2000-10-30 2000-12-13 Pfizer Ltd Process
EP1414455B1 (en) * 2001-06-11 2008-11-26 Vertex Pharmaceuticals Incorporated Isoquinoline inhibitors of p38
MX249034B (es) 2002-05-28 2007-09-14 Dimensional Pharm Inc Amidinas de tiofeno novedosas, composiciones de las mismas, y metodos para tratar enfermedades y condiciones mediadas por el complemento.
PE20040840A1 (es) * 2002-11-20 2004-12-30 Japan Tobacco Inc Derivados de 4-oxoquinolina como inhibidores de la integrasa del vih
GB0326964D0 (en) * 2003-11-19 2003-12-24 Glaxo Group Ltd Chemical compounds
US7531554B2 (en) * 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
WO2006090783A1 (ja) * 2005-02-25 2006-08-31 Kowa Co., Ltd. ４－フルオロイソキノリン－５－スルホニルハライド又はその塩の製造方法
ATE442842T1 (de) 2005-06-24 2009-10-15 Wilex Ag Verwendung von urokinase-inhibitoren zur behandlung und/oder vorbeugung von amyotrophischer lateralsklerose (als)
JP4669040B2 (ja) * 2006-03-06 2011-04-13 日本たばこ産業株式会社 ４−オキソキノリン化合物の製造方法
TWI795381B (zh) * 2016-12-21 2023-03-11 比利時商健生藥品公司 作為ｍａｌｔ１抑制劑之吡唑衍生物
CN106831575B (zh) * 2017-02-13 2019-04-16 北京六合宁远科技有限公司 一种1-氨基异喹啉-6-甲醇的制备方法
CN113877483B (zh) * 2021-07-20 2023-11-24 烟台宁远药业有限公司 医药中间体卤代异喹啉类硼酸的低温连续合成装置与方法
CN115286573A (zh) * 2022-08-04 2022-11-04 常州工程职业技术学院 一种1-烷氧基异喹啉化合物的绿色合成方法

Also Published As

Publication number Publication date
CA2306782C (en) 2005-05-17
AR015964A1 (es) 2001-05-30
KR20010031163A (ko) 2001-04-16
OA11348A (en) 2003-12-18
NO20001924D0 (no) 2000-04-13
HUP0004491A2 (en) 2001-03-28
NZ503390A (en) 2002-03-28
MA26552A1 (fr) 2004-12-20
DZ2624A1 (fr) 2003-03-08
GT199800159A (es) 2000-04-01
AU1150899A (en) 1999-05-10
AP9801366A0 (en) 1998-12-31
GB9721964D0 (en) 1997-12-17
ZA989412B (en) 2000-04-17
WO1999020608A1 (en) 1999-04-29
IS5412A (is) 2000-03-21
DE69814894D1 (de) 2003-06-26
US6248738B1 (en) 2001-06-19
PL340035A1 (en) 2001-01-15
ES2197514T3 (es) 2004-01-01
DE69814894T2 (de) 2003-12-24
CO4990959A1 (es) 2000-12-26
PE121299A1 (es) 1999-12-01
JP2001520221A (ja) 2001-10-30
PT1023268E (pt) 2003-09-30
IL135122A0 (en) 2001-05-20
CA2306782A1 (en) 1999-04-29
HUP0004491A3 (en) 2002-10-28
TR200001010T2 (tr) 2000-09-21
EP1023268A1 (en) 2000-08-02
EA200000320A1 (ru) 2000-10-30
HRP20000217A2 (en) 2000-10-31
CN1275979A (zh) 2000-12-06
EA002632B1 (ru) 2002-08-29
TNSN98185A1 (fr) 2005-03-15
NO20001924L (no) 2000-06-15
BG104328A (bg) 2000-12-29
AP959A (en) 2001-04-17
SK4872000A3 (en) 2001-12-03
UY25211A1 (es) 2000-12-29
HN1998000158A (es) 1999-02-09
ID23913A (id) 2000-05-25
ATE240943T1 (de) 2003-06-15
UY25291A1 (es) 1999-07-19
AU727315B2 (en) 2000-12-07
PA8461601A1 (es) 2000-05-24
YU21100A (sh) 2002-11-15
DK1023268T3 (da) 2003-06-10
JP3600794B2 (ja) 2004-12-15
EP1023268B1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
BR9812922A (pt) Isoquinolinas como inibidores de uroquinase
TR199902606T2 (xx) Farnesil transferaz� engelleyici kinazolinonlar.
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz (&#34;PARP&#34;) inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
TR199800720T2 (xx) Farnesil transferaz inhibe eden 2-kinolon t�revleri.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK1265606T3 (da) Celleadhæsionsinhibitorer
TR199902203T2 (xx) Fernesil transferaz engelleyici, N-veya C-ba�lant�l� imidazoller ile ikame edilmi� 1,8-anele kinolinon t�revleri.
DE69720773T2 (de) SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
ATE269312T1 (de) N-(amidinophenyl)-n&#39;-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
BR9810137A (pt) Composto, composição farmacêutica e método de tratamento ou prevenção de uma desordem tromoboembólica
BR9806413A (pt) Composto e uso do mesmo
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
ATE290382T1 (de) Heterozyklische kalium-kanal inhibitoren
DE69940480D1 (de) Carbocyclische kaliumkanalhemmer
BR9806752A (pt) Ftalazinonas.
BR0110998A (pt) Derivados de fenilglicina
ATE332903T1 (de) Kondensierte pyridoindolderivate
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
BR9811589A (pt) Derivados de hidroxicumaranona o-substituìda como agentes antitumores e antimetastáticos
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
BR9813719A (pt) Agentes terapêuticos

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements